Loading...
 
Translate Register Log In Login with facebookLogin and Register

100,000 IU Vitamin D weekly for 4 weeks is safe and effective for children – May 2019

Safety and effectiveness of stoss therapy in children with vitamin D deficiency.

J Paediatr Child Health. 2019 May 28. doi: 10.1111/jpc.14497.
Tannous P1, Fiscaletti M2, Wood N3,4, Gunasekera H4, Zurynski Y5, Biggin A6, Kilo T7, Hayes E8, Munns C6.

 Download the PDF from Sci-Hub via VitaminDWiki
Image

AIM:
Paediatric vitamin D (25-hydroxyvitamin D (25OHD)) deficiency can lead to nutritional rickets and extra-skeletal complications. Compliance with daily therapy can be difficult, making high-dose, short-term vitamin D (stoss) therapy attractive to correct vitamin D deficiency. We compared the effectiveness and safety of standard versus stoss therapy in treating childhood 25OHD deficiency.

METHODS:
Children aged 2-16 years with 25OHD <50 nmol/L were randomised to either standard (5000 IU daily for 80 days) or stoss (100 000 IU weekly for 4 weeks) cholecalciferol. Participants underwent an evaluation of effectiveness and safety. The 25OHD level, random spot calcium: creatinine ratio (Ca:Cr) and compliance were measured at 12 weeks.

RESULTS:
A total of 151 children were enrolled in the study (68 standard and 83 stoss), median age 9 years (inter-quartile range (IQR): 6-12 years). Baseline 25OHD levels were 26 nmol/L (IQR: 19-35 nmol/L) and 32 nmol/L (IQR: 24-39 nmol/L) in the standard and stoss groups, respectively. At 12 weeks, the median 25OHD level was significantly greater in the standard versus stoss group (81 vs. 67 nmol/L; P = 0.005); however, >80% of participants in both groups achieved sufficiency (25OHD > 50 nmol/L) and had normal urinary Ca:Cr, with no significant difference seen between groups. Compliance was similar in the two groups.

CONCLUSIONS:
Compared to stoss, standard therapy achieved higher 25OHD levels at 12 weeks; however, in both groups, there was a similar proportion of participants who achieved 25OHD sufficiency, with no evidence of toxicity. Unlike other studies, simplifying the treatment regimen did not improve compliance. These results support stoss therapy as an effective and safe alternative therapy for the treatment of paediatric vitamin D deficiency.

Created by admin. Last Modification: Friday June 14, 2019 13:22:45 GMT-0000 by admin. (Version 5)

Attached files

ID Name Comment Uploaded Size Downloads
12128 100,000 weekly.jpg admin 14 Jun, 2019 13:20 56.77 Kb 39
12127 10.1111@jpc.14497.pdf PDF 2019 admin 14 Jun, 2019 13:20 1.05 Mb 20
See any problem with this page? Report it (FINALLY WORKS)